NCT06552078 Activation of Biobank Registry for Bilio-pancreatic Diseases
| NCT ID | NCT06552078 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Pancreatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2021-06-09 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2021-06-09 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of establishing the biobank is to create a collection of biological material and clinical data, with a prospective and retrospective mold, in order to investigate the role of genetic predisposition in multifactorial bilio-pancreatic diseases, so that an evaluation of the possible association in the pathogenesis of exogenous factors with endogenous factors can be allowed. Multifactorial diseases are in fact an expression of genetic predisposition upon which one or more environmental stimuli act. Usually the aforementioned factors are not capable individually of triggering disease but, when simultaneously present, can cause the pathological phenotype. Therefore, it becomes important in the description of disease pathogenesis to identify as many risk factors for disease prevention and early diagnosis.
Eligibility Criteria
Inclusion Criteria: * age \>= 18 years * signed informed consent Exclusion Criteria: * age \< 18 years * unwilling to sign informed consent
Contact & Investigator
Paolo Giorgio Arcidiacono, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06552078 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06552078 currently recruiting?
Yes, NCT06552078 is actively recruiting participants. Contact the research team at capurso.gabriele@hsr.it for enrollment information.
Where is the NCT06552078 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06552078 clinical trial?
NCT06552078 is sponsored by IRCCS San Raffaele. The principal investigator is Paolo Giorgio Arcidiacono, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 2,000 participants.